Rolfing

This content has been reviewed and approved by

Jeremy R. Geffen, MD



 

What is Rolfing?

Rolfing is a systematic method of deep manipulation of the body’s soft tissues, designed to realign the body structurally and harmonize movement patterns in relation to gravity. The term refers to a range of systems based on the teachings of Dr. Ida Pauline Rolf, who founded The Rolf Institute of Structural Integration in 1971. Many modern modalities of "deep tissue bodywork" have evolved from Rolfing and the legacy of Dr. Rolf's theories.

Can Rolfing help people with cancer?
Yes. Rolfing is believed to enhance a person’s vitality and overall well-being. Many clients experience improved flexibility, posture, and structural alignment with the technique. Others report that soft tissue bodily asymmetries and symptoms of chronic musculoskeletal pain tend to resolve. Some people also experience powerful emotional release as physical stress and tensions in the body are relieved.

Rolfing alone is not a proven treatment for cancer, nor is it known to affect the biology of the disease or an individual’s outcome. It should not be used as a substitute for conventional care.

How does Rolfing work?
Rolfing is similar to deep tissue massage. It is based on the theory that “bound up” connective tissue (fascia) can restrict opposing muscles from functioning independently from each other, causing unnecessary, unhealthy, and often painful muscle tension and structural misalignments. Rolfing practitioners work to manually separate the bound up connective tissue fibers, to loosen them, allow increased circulation of blood and lymph, and improve structural alignment and movement patterns.

Rolfing is usually performed in a carefully planned, systemic sequence of 10, 1-hour weekly sessions. These are designed to gradually "unlock" the whole body, often beginning with the muscles that regulate and facilitate breathing. Clients lie on a massage table while the Rolfer carefully manipulates their connective tissues. There is a clearly defined, specific goal for each session, and an overall goal of cumulative results.

Historically, some people found Rolfing sessions to be painful. However, over the decades Rolfing has evolved into a practice that is more gentle than in its early origins.

Certified Rolfing practitioners receive formal training and certification at approved institutions in the United States and Europe. However, there is no formal government licensing procedure for Rolfing practitioners. It is always wise to ask practitioners about their credentials and training before working with them.

Are there any risks or complications associated with Rolfing?
Potentially, yes. Rolfing is generally regarded as being safe. However, it is important to find a qualified and experienced practitioner, and to use common sense with regard to obvious sites of disease or injury. Because it involves deep tissue manipulation, patients with skeletal, vascular, or clot disorders should consult a health care provider before undertaking Rolfing sessions. Discuss the use of Rolfing with your physician and be sure to tell your practitioner about any physical or other issues you are currently experiencing.

How can I find a qualified Rolfing practitioner?
It is important to select a practitioner who is qualified, experienced, properly credentialed, and trustworthy. Click here to learn more about how to do this.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
REFILE: Komen charity under microscope for funding, science

February 8, 2012 — NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Select news items provided by Reuters Health